Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer

被引:141
作者
Koehler, Tobias S. [2 ,4 ]
Kondapalli, Laxmi A. [2 ,5 ]
Shah, Amul
Chan, Sarah [6 ]
Woodruff, Teresa K. [2 ,3 ]
Brannigan, Robert E. [1 ,2 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA
[2] Northwestern Univ, Oncofertil Consortium, Chicago, IL 60611 USA
[3] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA
[4] So Illinois Univ, Sch Med, Div Urol, Springfield, IL USA
[5] Univ Penn, Sch Med, Div Reprod Endocrinol & Infertil, Philadelphia, PA 19104 USA
[6] Univ Maryland, Med Ctr, Div Urol, Baltimore, MD 21201 USA
关键词
Pediatric oncology; Cryopreservation; Fertility preservation; Cancer; Survey; CHILDHOOD-CANCER; SEMEN CRYOPRESERVATION; SPERM; ATTITUDES; TRANSPLANTATION; CHEMOTHERAPY; ONCOLOGISTS; INFERTILITY; SURVIVORS; BANKING;
D O I
10.1007/s10815-010-9504-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose Diminished reproductive capacity is a devastating consequence of life-sparing therapies for childhood malignancy. In 2006, the American Society of Clinical Oncology (ASCO) published fertility preservation recommendations (ASCOR) emphasizing the importance of early discussion and intervention for fertility preservation strategies. Using the Survey for Preservation of Adolescent REproduction (SPARE), we sought to determine fertility preservation attitudes and practice patterns post-ASCOR from pediatric oncology specialists nationwide. Materials and methods The SPARE survey consists of 22 questions assessing pediatric oncology specialists' attitudes and practice patterns toward fertility preservation. Broad perspectives on fertility preservation, including a willingness to discuss fertility, knowledge of current fertility preservation methods and awareness of ASCOR, were assessed. Results The majority of respondents acknowledged that fertility threats are a major concern for them and agreed that all pubertal cancer patients should be offered a fertility consultation, but only 46% reported they refer male pubertal cancer patients to a fertility specialist prior to cancer treatment >50% of the time, and only 12% reported they refer female pubertal cancer patients to a fertility specialist prior to cancer treatment >50% of the time. While 44% of respondents were familiar with the 2006 ASCOR, only 39% of those utilized them to guide decision-making in greater than half of their patients. Conclusion Our study demonstrates pediatric oncologists' motivation to preserve fertility in pediatric cancer patients; however, barriers to both gamete cryopreservation and referral to fertility specialists persist. Female pubertal patients are referred to fertility preservation specialists with much less frequency than are male pubertal patients, highlighting a disparity.
引用
收藏
页码:269 / 277
页数:9
相关论文
共 34 条
[1]  
[Anonymous], 1975, SEER CANC STAT REV
[2]  
[Anonymous], 2005, FERTIL STERIL, V83, P1622
[3]   Genetic and teratogenic effects of cancer treatments on gametes and embryos [J].
Arnon, J ;
Meirow, D ;
Lewis-Roness, H ;
Ornoy, A .
HUMAN REPRODUCTION UPDATE, 2001, 7 (04) :394-403
[4]   How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to Cryopreservation of embrya, oocytes, or ovaries [J].
Blumenfeld, Zeev .
ONCOLOGIST, 2007, 12 (09) :1044-1054
[5]   IS SEMEN CRYOPRESERVATION HELPFUL IN TESTICULAR CANCER [J].
BRACKEN, RB ;
SMITH, KD .
UROLOGY, 1980, 15 (06) :581-583
[6]  
Brannigan Robert E., 2007, V138, P28
[7]  
Dilley Kimberley J., 2007, V138, P50
[8]  
DOLIN G, 2009, SANTA CLARA LAW REV, P673
[9]  
Glaser A, 2000, MED PEDIATR ONCOL, V35, P114, DOI 10.1002/1096-911X(200008)35:2<114::AID-MPO5>3.0.CO
[10]  
2-K